The latest announcement is out from Acrux Limited ( (AU:ACR) ).
Acrux Limited has announced the quotation of 571,428 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of March 3, 2025. This move is part of a previously announced transaction, potentially enhancing the company’s market presence and providing additional liquidity for stakeholders.
More about Acrux Limited
Acrux Limited operates in the pharmaceutical industry, focusing on the development and commercialization of innovative drug delivery solutions. The company is known for its transdermal and topical drug delivery technologies, catering to a global market.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $6.33M
Find detailed analytics on ACR stock on TipRanks’ Stock Analysis page.